CLEO Further Expands Ovarian Cancer Trial with Siles Health

Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health

Download the PDF here.

This post appeared first on investingnews.com

Other news

26-12-2024 07:11

Wyoming Rare USA Secures Strategic Facility to Support Halleck Creek Project

26-12-2024 07:10

Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing

Enter Your Information Below To Receive Latest News, And Articles.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!